Agilent Technologies (A) Stock Price, News & Analysis

Company Overview

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Key Stats

• Today's Range: $101.36 to $103.50
• 50-Day Range: $98.97 to $138.07
• 52-Week Range: $96.43 to $155.35
• Volume: 1.77 million shs
• Average Volume: 1.86 million shs
• Market Capitalization: $29.19 billion
• P/E Ratio: 23.54
• Dividend Yield: 0.97%
• Price Target: $144.58
• Consensus Rating: Hold

Agilent Technologies Stock Analysis - MarketRank™

Agilent Technologies scored higher than 93% of companies evaluated by MarketBeat, and ranked 85th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.2 / 5
• Analyst Rating: Hold

Consensus Rating

Agilent Technologies has received a consensus rating of Hold. The company's average rating score is 2.46, and is based on 6 buy ratings, 7 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Agilent Technologies has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 9.03%

Earnings Growth

Earnings for Agilent Technologies are expected to grow by 9.03% in the coming year, from $5.54 to $6.04 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Agilent Technologies is 23.54, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.40.

Price to Earnings Ratio vs. Sector

The P/E ratio of Agilent Technologies is 23.54, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 21.94.

Price to Earnings Growth Ratio

Agilent Technologies has a PEG Ratio of 2.89. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Agilent Technologies has a P/B Ratio of 4.99. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.27% of the float of Agilent Technologies has been sold short.

Short Interest Ratio / Days to Cover

Agilent Technologies has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Agilent Technologies has recently decreased by 7.67%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Agilent Technologies has a dividend yield of 0.97%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Agilent Technologies does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Agilent Technologies is 22.76%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Agilent Technologies will have a dividend payout ratio of 16.39% next year. This indicates that Agilent Technologies will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 3.6 / 5
• Environmental Score: -1.83

Percentage of Shares Shorted

1.27% of the float of Agilent Technologies has been sold short.

Short Interest Ratio / Days to Cover

Agilent Technologies has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Agilent Technologies has recently decreased by 7.67%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 3.3 / 5
• News Sentiment: 0.92

News Sentiment

Agilent Technologies has a news sentiment score of 0.92. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.53 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 39 news articles for Agilent Technologies this week, compared to 14 articles on an average week.

Search Interest

Only 29 people have searched for A on MarketBeat in the last 30 days. This is a decrease of -26% compared to the previous 30 days.

MarketBeat Follows

15 people have added Agilent Technologies to their MarketBeat watchlist in the last 30 days. This is an increase of 114% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Agilent Technologies insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $731,229.00 in company stock.

Percentage Held by Insiders

Only 0.26% of the stock of Agilent Technologies is held by insiders.

Percentage Held by Institutions

87.42% of the stock of Agilent Technologies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

A Stock Analysis - Frequently Asked Questions

How have A shares performed this year?

Agilent Technologies' stock was trading at $134.34 at the beginning of 2025. Since then, A stock has decreased by 23.8% and is now trading at $102.3840.
View the best growth stocks for 2025 here.

How were Agilent Technologies' earnings last quarter?

Agilent Technologies, Inc. (NYSE:A) announced its quarterly earnings data on Wednesday, February, 26th. The medical research company reported $1.31 earnings per share for the quarter, topping the consensus estimate of $1.27 by $0.04. The medical research company earned $1.68 billion during the quarter, compared to analysts' expectations of $1.67 billion. Agilent Technologies had a net margin of 19.27% and a trailing twelve-month return on equity of 25.56%.
Read the conference call transcript.

Does Agilent Technologies have any subsidiaries?

The following companies are subsidiaries of Agilent Technologies: Resolution Bioscience, BioTek Instruments, ACEA BIO, Young In Scientific Co. Ltd, ProZyme Inc, ULTRA Scientific, Genohm, and others.

Who are Agilent Technologies' major shareholders?

Top institutional investors of Agilent Technologies include GAMMA Investing LLC (0.22%), Rhumbline Advisers (0.20%), Fenimore Asset Management Inc (0.06%) and Vaughan Nelson Investment Management L.P. (0.05%). Insiders that own company stock include Michael R Mcmullen, Jacob Thaysen, Henrik Ancher-Jensen, Boon Hwee Koh, Heidi Fields, Michael Tang, Dominique Grau, Padraig Mcdonnell, Daniel K Podolsky, Rodney Gonsalves and Philip Binns.
View institutional ownership trends.

How do I buy shares of Agilent Technologies?

Shares of A stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Agilent Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Agilent Technologies investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), DiamondRock Hospitality (DRH), The RMR Group (RMR), Voyager Therapeutics (VYGR) and iShares Micro-Cap ETF (IWC).

Company Calendar

• Record date for 1/22 Dividend: 12/31/2024
• Ex-Dividend for 1/22 Dividend: 12/31/2024
• Dividend Payable: 1/22/2025
• Last Earnings: 2/26/2025
• Record date for 4/23 Dividend: 4/01/2025
• Ex-Dividend for 4/23 Dividend: 4/01/2025
• Today: 4/19/2025
• Dividend Payable: 4/23/2025
• Next Earnings (Estimated): 5/28/2025
• Fiscal Year End: 10/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Analytical instruments
• Sub-Industry: Life Sciences Tools & Services
• Current Symbol: NYSE:A
• CIK: 1090872
• Web: www.agilent.com
• Phone: (800) 227-9770
• Fax: 408-345-8474
• Employees: 17,900
• Year Founded: 1999

Price Target and Rating

• Average Stock Price Target: $144.58
• High Stock Price Target: $165.00
• Low Stock Price Target: $115.00
• Potential Upside/Downside: +41.2%
• Consensus Rating: Hold
• Rating Score (0-4): 2.46
• Research Coverage: 13 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $4.35
• Trailing P/E Ratio: 23.54
• Forward P/E Ratio: 18.48
• P/E Growth: 2.89
• Net Income: $1.29 billion
• Net Margins: 19.27%
• Pretax Margin: 22.73%
• Return on Equity: 25.56%
• Return on Assets: 13.47%

Debt

• Debt-to-Equity Ratio: 0.56
• Current Ratio: 2.20
• Quick Ratio: 1.66

Sales & Book Value

• Annual Sales: $6.53 billion
• Price / Sales: 4.47
• Cash Flow: $6.24 per share
• Price / Cash Flow: 16.40
• Book Value: $20.53 per share
• Price / Book: 4.99

Miscellaneous

• Outstanding Shares: 285,103,000
• Free Float: N/A
• Market Cap: $29.19 billion
• Optionable: Optionable
• Beta: 1.19